Market Recap and Key Insights
This morning’s “Morning Meeting” livestream from Jim Cramer’s CNBC Investment Club provided some insights into Monday’s market performance. The S&P 500 faced a dip as investors shifted focus from tech stocks to value-driven investments. For instance, shares of Broadcom dropped more than 4%, while financial powerhouses like Wells Fargo and Goldman Sachs saw gains.
Looking ahead, there’s anticipation in the air for significant economic reports this week. Key announcements include October retail sales and November job figures on Tuesday, followed by the consumer price index data for November on Thursday.
In terms of stock ratings, Costco was downgraded from a 1 to a 2, which indicates a hold recommendation. Jim raised concerns about Costco’s performance in his Sunday column, noting that not only has the stock fallen behind the market this year, but membership renewals are happening at lower rates. This trend has been evident over the past few quarters. If conditions change, there may be a prompt decision to sell.
Evercore ISI recently initiated a buy rating for both Honeywell and GE Vernova. Analysts highlighted that Honeywell’s upcoming spin-off of its aerospace division could enhance revenue from its automation sector. As for GE Vernova, its solid earnings growth is backed by electrification and a robust power backlog. Even though we consider GE Vernova a strong stock, we’ve downgraded it to a 2 following a small profit on Monday after last week’s surge to record highs.
The stocks mentioned in Monday’s wrap-up included ServiceNow, Masco, Zoetis, Texas Instruments, and Dollar General. Subscribers of Jim Cramer’s CNBC Investment Club benefit from trade alerts before each transaction. Jim typically waits 45 minutes after sending out an alert to execute trades in his charitable trust’s portfolio, and if a stock is discussed on CNBC, he will hold off on trading for 72 hours.
This information regarding the investment club relies on the applicable Terms of Use and Privacy Policy. Importantly, no fiduciary duties exist from the receipt of this information, nor are specific results or benefits guaranteed.





